Capital World Investors
PBYI icon

Capital World Investors’s Puma Biotechnology PBYI Stock Holding History

Capital World Investors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-104,734
Closed -$25M – 549
2014
Q3 		$25M Buy
+104,734
New +$21.5M 0.01% 414

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors's PBYI Position: Q4 2014 in Review

Capital World Investors sold out of Puma Biotechnology (PBYI) in Q4 2014, closing a stake of 104,734 shares — an estimated $25M sold.

Capital World Investors first reported a position in PBYI in Q3 2014 and held it in 1 quarter. The position peaked at $25M in Q3 2014. 189 funds tracked by Wall St. Rank hold PBYI as of Q4 2014.

  • Capital World Investors reported no remaining Puma Biotechnology position as of Q4 2014 after selling out during the quarter.
  • Capital World Investors sold 104,734 Puma Biotechnology shares in Q4 2014, an estimated $25M.
  • Capital World Investors first reported a position in Puma Biotechnology in Q3 2014 and held it in 1 quarter.
  • Capital World Investors's Puma Biotechnology position peaked at $25M in Q3 2014.
  • 189 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2014.

Based on Capital World Investors's 13F filing for Q4 2014, filed 13 Feb 2015.